Clinical Trials Logo

Obesity and Overweight clinical trials

View clinical trials related to Obesity and Overweight.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03707990 Completed - Clinical trials for Obesity and Overweight

A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or Obese

Start date: October 15, 2018
Phase: Phase 1
Study type: Interventional

The study is looking at possible new medicines for weight control in people with high body weight. The study looks at how the new medicines work in the body. The study consists of two parts. If participants take part in Part 1, they will either get a single dose of NNC0165-1875 or a "dummy" medicine (placebo). If participants take part in Part 2, they will either get a single dose of NNC0165-1875 or "dummy" medicine and also a single dose of semaglutide. Which treatment participants get is decided by chance. For Part 1 participants will get 1 injection. For Part 2 participants will get 2 injections. A study nurse at the clinic will inject the medicine with a thin needle in a skin fold in the stomach. The study will last for about 9 weeks. Participants will have 7 visits to the clinic with the study doctor.

NCT ID: NCT02630602 Completed - Clinical trials for Obesity and Overweight

Functional Goat Cheese Effect in Lipid Profile Change

LODYN
Start date: March 2014
Phase: Phase 4
Study type: Interventional

The purpose this study was to evaluate the therapeutic effect of a functional goat cheese on obese and overweight people with altered lipid profile. The functional goat cheese containing polyunsaturated fatty acid, in amounts exceeding other cheese, was developed to benefit cardiovascular health of people who need to normalize lipid profile; which in the long term can contribute to the prevention of cardiovascular diseases.

NCT ID: NCT02347267 Completed - Clinical trials for Obesity and Overweight

Reduction in Consumption of Sweetened Beverages on Weight, Body Composition and Blood Pressure in Young Adults

Start date: May 2012
Phase: N/A
Study type: Interventional

The impact of reduction in consumption of caloric and no caloric sweetened beverages on: - weight - body composition - blood pressure - young adults

NCT ID: NCT02024425 Completed - Clinical trials for Obesity and Overweight

Functional Bioactive Supplement Effect in Lost Weight Treatment

ALIBIRDII
Start date: September 2013
Phase: Phase 4
Study type: Interventional

The purpose this study is to evaluate the therapeutic effect of a functional bioactive supplement associated with a hypocaloric equilibrated diet to treat obese and overweight individuals. The functional bioactive supplement, containing antioxidant extracted from rosemary, oligosaccharides derived from lactulose and bioactive peptides, was developed to satiety control, improves of anti-inflammatory response and antioxidant defense mechanisms as well as to weight loss.

NCT ID: NCT01889225 Completed - Clinical trials for Obesity and Overweight

Obesity and Mortality

Start date: January 2008
Phase: N/A
Study type: Observational

Previous analyses of the National Health and Nutrition Examination Survey have suggested that the mortality rate associated with obesity has decreased over calendar time in the U.S. population, potentially due to improvements in the medical care of obesity and its associated diseases. The primary aim of this project is to evaluate whether this reduction in the detrimental association of obesity with mortality rate over calendar time is supported by other data from U.S. prospective studies.